Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Polycystic Ovary Syndrome × Progesterone × Clear all

Phase

Phase NA 7 Phase EARLY_PHASE1 3 Phase 4 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Hyperandrogenism 1 Brain Neoplasms 1

Interventions

Metformin 6 Letrozole 3 Pharmaceutical Preparations 2 semaglutide 1 salicylsalicylic acid 1 mirabegron 1 drospirenone and ethinyl estradiol combination 1 Vitamins 1 Thioctic Acid 1 Progesterone 1 Itraconazole 1 Inositol 1 Hydroquinones 1 Gonadotropin-Releasing Hormone 1 Flutamide 1 Flour 1 Fish Oils 1 Docosahexaenoic Acids 1 Clomiphene 1 Ascorbic Acid 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01428089 2023-11-02

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

University of Virginia

Phase 1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡